Log in
Request a free trial
Request a free trial
Log in
Products
Solutions
Data
News & Analysis
About
News & Analysis
driven by the PitchBook Platform
subscribe
Private Equity
Venture Capital
M&A
More
reports
videos
All
Report Center
Industry Updates
In the Spotlight
Blog
reports
New Investor Trio Leads $12M Series B Financing for Coferon
July 18, 2012
Share:
New York-based biotechnology company
Coferon
has closed on $12 million of Series B financing led by new investors
Hatteras Venture Partners
,
MedImmune Ventures
and
Ascent Biomedical Ventures
. Currently, Coferon is conducting research and development of epignetics and anti-infectives.
Coferon
Drug Discovery
Stony Brook, NY
$12 million
Series B
VIEW DETAILS
Lead Investors
Ascent Biomedical Ventures
Hatteras Venture Partners
MedImmune Ventures
Share:
Tags
Private Equity
Venture Capital
related
Here are the PE & VC firms most affected by the solar eclipse
PE doubles down on VC-backed startups
Vision Fund 101: Inside SoftBank's $93B vehicle
VC & PE analyst compensation: pre-MBA vs. post-MBA
MOST READ ARTICLES
The sky's the limit: 3 VC-backed companies making flying cars
Can VCs keep pace with the ICO market?
Investor Spotlight: The rapid rise of Thoma Bravo
VC investment in US agtech keeps growing [datagraphic]
Timeline: In seven years, WeWork built a $21B co-working empire
trending reports
3Q 2017
PitchBook Artificial Intelligence & Machine Learning Market Map
August 10, 2017
1H 2017
VC Valuations Report
August 09, 2017
A better way to do
VC, PE and M&A
The PitchBook Platform
